Nrf2- and p53-inducible REDD2/DDiT4L/Rtp801L confers pancreatic β-cell dysfunction, leading to glucose intolerance in high-fat diet-fed mice

By sjmartinez • May 24, 2025

Yamada Y, Urakawa N, Tamiya H, Sakamoto S, Takahashi H, Harada N, Kitakaze T, Izawa T, Matsumua S, Yoshihara E, Inui H, Mashimo T, Yamaji R. Nrf2- and p53-inducible REDD2/DDiT4L/Rtp801L confers pancreatic β-cell dysfunction, leading to glucose intolerance in high-fat diet-fed mice. J Biol Chem. 2025 May 21:110271. doi: 10.1016/j.jbc.2025.110271. Epub ahead of print. PMID: 40409543.

Tags: DDiT4L, DNA damage-inducible transcript 4-like, Endocrinology, gene knockout, Harbor UCLA, Nrf2, nuclear factor erythroid 2 related factor 2, oxidative stress p53, pancreatic β-cell, Publications, REDD2, streptozotocin, Stress response, STZ, the regulated in development and DNA damage response 2, Type 2 diabetes

Rebuilding the foundation: recommendations from the Summit to Revitalize Primary Care (Rev PC)

Summit to Revitalize Primary Care Writing Committee*; Jerant A, Kravitz RL, Fenton JJ, Lyles CR, Grumbach K, Henderson MC, Ritley D, Brandt M, Cohen D,[...]

Reaching Veterans Most in Need: Evaluating Engagement in a National Telephone Lifestyle Coaching Program for Veterans

Clair K, Bean-Mayberry B, Chanfreau C, Hurley S, Pear E, Goldstein MG, Kim J, Raffa SD, Moin T, Finley EP, Hamilton A, Farmer MM. Reaching[...]

Efficacy and safety of relacorilant for the treatment of patients with Cushing’s syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study

Pivonello R, Arnaldi G, Auchus RJ, Badiu C, Busch RS, Cannavò S, Dischinger U, Dobri GA, Donegan DM, Elenkova A, Fazeli PK, Feelders RA, Garcia-Centeno[...]